EP3228315
PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.10.2011EP published:
25.11.2020EP application number:
17159560.6
EPO information:
European Patent Register
Max expiry date:
26.10.2031
Title:
PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS
Timeline
Today
27.10.2011EP application
25.11.2020EP Publication
Owner
Name:
Amgen Research (Munich) GmbHAddress:
Staffelseestrasse 2, 81477 München, DE
Inventor
Name:
ZUGMAIER, GerhardAddress:
81477 Muenchen, DE
Name:
NAGORSEN, DirkAddress:
81477 Muenchen, DE
Name:
SCHEELE, JuergenAddress:
81477 Muenchen, DE
Priority
Number:
412229 PDate:
10.11.2010Country:
US
Classification
Categories:
A61K 31/573, A61K 39/395, C07K 16/28